Clinical trial
Analysis of Cytokines in Response to Treatment of Diabetic Macular Edema With 0.3mg Lucentis
NCT03097068 is registered in ClinicalTrials.gov with Vitreo-Retinal Associates, Michigan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of Cytokines in Response to Treatment of Diabetic Macular Edema With 0.3mg Lucentis
- Lead sponsor
- Vitreo-Retinal Associates, Michigan
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 19, 2017
- Completion date
- February 2, 2018
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic macular edema